版本:
中国

BRIEF-Catalyst Pharmaceuticals' board entered into amendment no. 1 to rights agreement

Sept 20 Catalyst Pharmaceuticals Inc

* On September 19, 2016, board unanimously approved, and entered into amendment no. 1 to rights agreement - SEC filing

* Under amendment, outside expiration date of rights granted under rights agreement has been extended from Sept 20, 2016 to Sept 20, 2019

* Amends certain rights agreement, dated Sept 20, 2011, between Co and Continental Stock Transfer and Trust Co, as rights agent Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐